U.S. FDA grants emergency use for Pfizer’s COVID-19 vaccine for kids aged 5-11

The U.S. Food and Drug Administration (FDA) granted emergency use authorization for Pfizer’s COVID-19 vaccine for children ages five to 11. The Centers for Disease Control and Prevention are set to meet next week to consider their own recommendation for that age group. Meanwhile, public employees are pushing back in cities like New York and Chicago, where vaccine mandates have or are set to go into effect.

• Pfizer expects $29B in COVID-19 vaccine sales next year
• U.S. shipping millions of COVID-19 vaccines for younger kids ahead of CDC decision
• Moderna says FDA delaying decision on its adolescent COVID-19 vaccine shot